World leader in diagnostic industry selects clinivation Global xi to manage its medical products approvals and submissions.
Natick, MA, August 27, 2007 – clinivation, Inc. announced today that Siemens Medical Solutions Diagnostics, subsidiary of Siemens AG (NYSE: SI), has selected the clinivation Global Enterprise Solution for Market Clearance Management Market Clearance Management solution.”Siemens is clearly a worldwide leader in the advancement of diagnostics, complete with an extensive portfolio of innovative products, technologies, and services across a wide range of medical specialties,” said Joseph Kozikowski, M.D., clinivation’s Chief Executive Officer. “We are delighted Siemens’ senior management has selected clinivation Global xi to help impact market clearance operations to better achieve their sales and marketing objectives,” he continued.
Clinivation Global xi software enables medical device companies to sell more products to more countries faster and easier than ever before. Clinivation Global xi is the first complete solution targeted at automating the business processes for market clearance operations worldwide.
About Siemens Medical Solutions Diagnostics
Siemens Medical Solutions Diagnostics offers a broad portfolio of performance-driven diagnostic solutions that assist in the diagnosis, monitoring and management of disease. Products and services bring together the right balance of science, technology, and practicality across the healthcare continuum to empower medical professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe.
For additional information, visit www.siemens.com/diagnostics.
About Siemens Medical Solutions
Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world’s largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics – such as Diagnostic Products Corporation and Bayer Diagnostics – mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30).
Further information can be found by visiting www.siemens.com/medical.
